S patients", "sentences": [], "annotations": [], "relations": []}, {"offset": 50916, "infons": {"fpage": "186", "issue": "2", "lpage": "191", "name_0": "surname:Miravalle;given-names:A", "name_1": "surname:Jensen;given-names:R", "name_2": "surname:Kinkel;given-names:R", "pub-id_pmid": "20937940", "section_type": "REF", "source": "Arch Neurol", "type": "ref", "volume": "68", "year": "2011"}, "text": "Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy", "sentences": [], "annotations": [], "relations": []}, {"offset": 51039, "infons": {"fpage": "392", "issue": "3", "lpage": "395", "name_0": "surname:Killestein;given-names:J", "name_1": "surname:Vennegoor;given-names:A", "name_2": "surname:Strijbis;given-names:EM", "pub-id_pmid": "20661928", "section_type": "REF", "source": "Ann Neurol", "type": "ref", "volume": "68", "year": "2010"}, "text": "Natalizumab drug holiday in multiple sclerosis: poorly tolerated", "sentences": [], "annotations": [], "relations": []}, {"offset": 51104, "infons": {"fpage": "1858", "issue": "22", "lpage": "1865", "name_0": "surname:O'Connor;given-names:PW", "name_1": "surname:Goodman;given-names:A", "name_2": "surname:Kappos;given-names:L", "pub-id_pmid": "21543733", "section_type": "REF", "source": "Neurology", "type": "ref", "volume": "76", "year": "2011"}, "text": "Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis", "sentences": [], "annotations": [], "relations": []}, {"offset": 51206, "infons": {"fpage": "1491", "issue": "17", "lpage": "1498", "name_0": "surname:Fox;given-names:RJ", "name_1": "surname:Cree;given-names:BA", "name_2": "surname:De Seze;given-names:J", "pub-id_pmid": "24682966", "section_type": "REF", "source": "Neurology", "type": "ref", "volume": "82", "year": "2014"}, "text": "MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study", "sentences": [], "annotations": [], "relations": []}, {"offset": 51300, "infons": {"fpage": "1665", "issue": "9", "lpage": "1669", "name_0": "surname:Havla;given-names:J", "name_1": "surname:Gerdes;given-names:LA", "name_2": "surname:Meinl;given-names:I", "pub-id_pmid": "21431380", "section_type": "REF", "source": "J Neurol", "type": "ref", "volume": "258", "year": "2011"}, "text": "De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate", "sentences": [], "annotations": [], "relations": []}, {"offset": 51425, "infons": {"fpage": "395", "issue": "3", "lpage": "399", "name_0": "surname:West;given-names:TW", "name_1": "surname:Cree;given-names:BA", "pub-id_pmid": "20818793", "section_type": "REF", "source": "Ann Neurol", "type": "ref", "volume": "68", "year": "2010"}, "text": "Natalizumab dosage suspension: are we helping or hurting?", "sentences": [], "annotations": [], "relations": []}, {"offset": 51483, "infons": {"fpage": "87", "issue": "1", "lpage": "94", "name_0": "surname:Rossi;given-names:S", "name_1": "surname:Motta;given-names:C", "name_2": "surname:Studer;given-names:V", "pub-id_pmid": "22741530", "section_type": "REF", "source": "Eur J Neurol", "type": "ref", "volume": "20", "year": "2013"}, "text": "Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab", "sentences": [], "annotations": [], "relations": []}, {"offset": 51577, "infons": {"fpage": "520", "issue": "4", "lpage": "526", "name_0": "surname:Sangalli;given-names:F", "name_1": "surname:Moiola;given-names:L", "name_2": "surname:Ferre;given-names:L", "pub-id_pmid": "25877065", "section_type": "REF", "source": "Mult Scler Relat Disord", "type": "ref", "volume": "3", "year": "2014"}, "text": "Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patients", "sentences": [], "annotations": [], "relations": []}, {"offset": 51690, "infons": {"fpage": "1170", "issue": "6", "lpage": "1177", "name_0": "surname:Sorensen;given-names:PS", "name_1": "surname:Koch-Henriksen;given-names:N", "name_2": "surname:Petersen;given-names:T", "name_3": "surname:Ravnborg;given-names:M", "name_4": "surname:Oturai;given-names:A", "name_5": "surname:Sellebjerg;given-names:F", "pub-id_pmid": "24728334", "section_type": "REF", "source": "J Neurol", "type": "ref", "volume": "261", "year": "2014"}, "text": "Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients", "sentences": [], "annotations": [], "relations": []}, {"offset": 51807, "infons": {"fpage": "82", "lpage": "87", "name_0": "surname:Fagius;given-names:J", "name_1": "surname:Feresiadou;given-names:A", "name_2": "surname:Larsson;given-names:EM", "name_3": "surname:Burman;given-names:J", "pub-id_pmid": "28283113", "section_type": "REF", "source": "Mult Scler Relat Disord"